High prevalence of the anti-nucleosome antibodies (anti-NCS) in patients with systemic lupus erythematosus (SLE) of recent-onset.

被引：0
|
作者：
Simón, JA [1 ]
Cabiedes, J [1 ]
Sánchez-Guerrero, J [1 ]
Ortiz, E [1 ]
Varela, JA [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S296 / S296
页数：1
相关论文
共 50 条
  • [31] Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies
    Pradhan, Vandana D.
    Patwardhan, Manisha M.
    Ghosh, Kanjaksha
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2010, 76 (02): : 145 - 149
  • [32] The additional role of anti-nucleosome antibodies in the prediction of renal damage in systemic lupus erythematosus based on CSTAR (XXV)
    Ding, Yufang
    Zhou, Yangzhong
    Zhao, Jiuliang
    Wu, Chanyuan
    Zhang, Shangzhu
    Jiang, Nan
    Qian, Junyan
    Zhang, Li
    Li, Jing
    Xu, Dong
    Leng, Xiaomei
    Wang, Qian
    Tian, Xinping
    Li, Mengtao
    Zeng, Xiaofeng
    LUPUS, 2024, 33 (09) : 986 - 997
  • [33] Isolation of anti-nucleosome antibodies from the plasma of lupus nephritis patients
    Suenaga, R
    Mitamura, K
    Abdou, NI
    CLINICAL RHEUMATOLOGY, 1998, 17 (03) : 189 - 194
  • [34] Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus
    González, C
    Garcia-Berrocal, B
    Herráez, O
    Navajo, JA
    González-Buitrago, JM
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (03) : 266 - 272
  • [35] Prevalence of anti-nucleosome antibodies in connective tissue diseases
    Amoura, Z
    Cacoub, P
    Chabre, H
    Musset, L
    Wechsler, B
    Papo, T
    Koutouzov, S
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 326 - 326
  • [36] Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity
    Shang, Xiaoying
    Ren, Lisheng
    Sun, Guirong
    Yu, Teng
    Yao, Yuan
    Wang, Lin
    Liu, Fenghai
    Zhang, Lijun
    He, Xiaqin
    Liu, Mingjun
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (02) : 407 - 418
  • [37] Incidence-rate, time of presentation, and risk factors for thrombosis in patients with systemic lupus erythematosus (SLE) of recent-onset.
    García-Sosa, I
    Romero-Díaz, J
    Sánchez-Guerrero, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S695 - S695
  • [38] Anti-Nucleosome Antibodies As a Predictor Factor For Relapses In Clinically Quiescent Systemic Lupus Erythematosus: Results Of a Prospective Cohort Study
    Sanchez-Mosco, Dalia
    Alejandra Gandarilla-Martinez, Nadia
    Selene Fajardo-Robledo, Nicte
    Diaz-Rizo, Valeria
    Amali Zavaleta-Muniz, Soraya
    Huerta, Miguel
    Trujillo, Xochitl
    Nava, Arnulfo
    German Cardona-Munoz, Ernesto
    Francisco Munoz-Valle, Jose
    Ivan Gamez-Nava, Jorge
    Gonzalez-Lopez, Laura
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1087 - S1087
  • [39] Anti-nucleosome antibodies as a marker of active proliferative lupus nephritis
    Bigler, C.
    Lopez-Trascasa, M.
    Potlukova, E.
    Moll, S.
    Danner, D.
    Schaller, M.
    Trendelenburg, M.
    SWISS MEDICAL WEEKLY, 2008, 138 : 53S - 53S
  • [40] Anti-nucleosome Antibody Expression in Patients with Systemic Lupus Erythematosus Complicated with Rash and its Correlation with Disease Severity
    Hu, Shan
    Su, Jiangwei
    Fan, Tao
    Liu, Jinhua
    Li, Sheng
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 : 76 - 77
12345